28 model-driven-engineering Postdoctoral positions at University of Nebraska Medical Center
Sort by
Refine Your Search
-
immunology and molecular biology techniques. Preferred experiences are with mouse models of kidney injury and microsurgical skills in particular. Successful applicant’s work will include investigation
-
Position Summary Working on projects on cellular and animal models for drug resistance in PDAC and ovarian cancer Required Qualifications Ph.D. or equivalent degree in cell biology, cancer biology or similar
-
exposure models of Fetal Alcohol Spectrum Disorders (FASD). We are currently using several approaches including multiphoton in vivo imaging, auditory measurements, behavioral methods and electrophysiology
-
brain cancer) with its most aggressive form. This lab is seeking a highly motivated postdoctoral candidate with expertise in the molecular cell biology and animal model studies. The candidate should be
-
of working with, and breeding rodent models. Excellent communication skills. An interest in placental and/or fetal brain development and experience of genomics or transcriptomics and bioinformatics would be
-
a major economic engine for the state of Nebraska. Led by Chancellor Jeffrey P. Gold, M.D., UNMC has six colleges, two institutes and a graduate studies program, serving nearly 4,000 students in
-
adenocarcinoma (PDA) pathogenesis. The murine models of distinct genetic subtypes of pancreas cancer that we have developed form the basis of our integrated, systematic, and multidisciplinary research program. Our
-
comfortable with handling research animals (rodent models) and conducting developmental biology and HIV-1 virology linked experiments in these animal models. . In addition, ability to work as a part of a team
-
and working experience in BSL2, BSL3 and ABSL2 and ABSL3 labs preferred. Research interests include animal models as synergetic platform for preclinical development of therapeutics and molecular biology
-
barrier breakdown in patient-derived xenograft mouse glioma models. His current focus is on engineering nanoparticles for more targeted laser therapeutics and exploring new drug discovery for pediatric high